After its pandemic success, Israeli-Canadian startup SaNOtize is hoping that clinical trials will show that its pioneering antiviral nasal spray can be used to treat the flu and other upper respiratory viruses.
Read more here.
After its pandemic success, Israeli-Canadian startup SaNOtize is hoping that clinical trials will show that its pioneering antiviral nasal spray can be used to treat the flu and other upper respiratory viruses.
Read more here.
![[Kenna Security in CB Insights] The periodic table of cybersecurity startups](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
